Product Program year 2024 Source: CMS Open Payments

Synvisc-One

Device Orthopedics/Orthopedic Surgery

PDI 20358468019114

Open in the dashboard

General payments

$58,599

2,876 payments

Research payments

$0

0 payments

Through program year 2024, $58,599 in general payments and $0 in research payments were reported against Synvisc-One (Orthopedics/Orthopedic Surgery).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $1,353 67
2023 General $32,433 1,496
2022 General $14,870 753
2021 General $9,942 560

Breakdown

Who paid General payments · program years 2021–2024
  1. Sanofi-Aventis U.S. LLC $58,479 2,870 payments
  2. Genzyme Corporation $119 6 payments
Top recipients General payments · program year 2024
  1. Michael Trimba Interventional Pain Medicine · Brooklyn, NY $68 5% · 2 payments
  2. Yuriy Trimba Anesthesiology · Dallas, TX $68 5% · 2 payments
  3. Lyudmila Trimba Physical Medicine & Rehabilitation · Bay Shore, NY $34 3% · 1 payment
  4. Ryan Kehoe Orthopaedic Surgery · Brookfield, WI $29 2% · 1 payment
  5. Brian Puskas Orthopaedic Surgery · Tigard, OR $28 2% · 1 payment

The top 5 of 65 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Orthopaedic Surgery $376 29% · 18 practitioners
  2. Physician Assistant $233 18% · 11 practitioners
  3. Interventional Pain Medicine Pain Medicine $97 7% · 3 practitioners
  4. Physician Assistant, Surgical Physician Assistant $96 7% · 5 practitioners
  5. Sports Medicine Orthopaedic Surgery $94 7% · 5 practitioners

The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. New York $229 17% · 6 recipients
  2. Texas $212 16% · 10 recipients
  3. Illinois $176 13% · 10 recipients
  4. New Jersey $161 12% · 10 recipients
  5. Oregon $112 8% · 4 recipients

The top 5 of 18 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

2,876 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record